Are Novel Allergen or Hydrolysed Diets an Effective Means of Reducing the Gastro-intestinal Signs in Dogs With Inflammatory Bowel Disease When Compared to Oral Prednisolone?

Adam Swallow

Published:  20/03/2017    in:  Knowledge Summaries
Audio Summary:


Clinical bottom line

Novel allergen or hydrolysed diets are a valid modality for the management of gastro-intestinal symptoms in dogs with chronic enteropathy, however bias in case selection in the literature means a direct comparison of dietary modification versus prednisolone was not able to be achieved. Further prospective trials would be needed to better answer this PICO.

Open AccessPeer Reviewed
Full Text:

HTML PDF Audio Summary

Click to see References Click to hide References

  1. Allenspach, K. Wieland, B. Grone, A. (2007) Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. Journal of Veterinary Internal Medicine, 21 (4), pp. 700-8. DOI:
  2. Craven, M. et al. (2004) Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995- 2002). Journal of Small Animal Practice, 45 (7), pp. 336-42. DOI:
  3. Kawano, K. et al. (2016) Prevalence of food-responsive enteropathy among dogs with chronic enteropathy in Japan. Journal of Veterinary Medical Science, 78 (8), pp. 1377-1380. DOI:
  4. Mandigers, P.J. et al. (2010) A randomized, open-label, positively-controlled field trial of a hydrolyzed protein diet in dogs with chronic small bowel enteropathy. Journal of Veterinary Internal Medicine, 24 (6), pp. 1350-7. DOI:
  5. Marks, S.L. Laflamme, D.P. McAlose, D. (2002) Dietary trial using a commercial hypoallegenic diet containing hydrolyzed protein for dogs with inflammatory bowel disease. Veterinary Therapeutics, 3 (2), pp. 109-18.

  • There are currently no refbacks.

Copyright (c) 2017 Adam Swallow

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Made possible through a project grant from the RCVS Council.